Ruthenium-containing catalysts can be homogeneous or heterogeneous in organic reactions such as olefin metathesis. Benzeneruthenium (II) chloride dimer, ruthenium (III) iodide hydrate, ruthenium (IV) oxide, triruthenium dodecacarbonyl, and chlorotris (triphenylphosphine) ruthenium(II) acetate are a few examples of commercially available ruthenium catalysts. Alkylation, arylation, allylation, cyclopropanation, hydroformylation, cyclization, hydrogenation, hydrosilylation, isomerization, hydroxylation, oxidation, olefin metathesis, tandem reactions, transfer hydrogenation, and water splitting are some of the organic reactions that use it. Ruthenium catalysts are used in the synthesis of biologically active compounds like Swainsonine, Castanospermine, and Epothilone C. Chemotherapeutic agents, smart materials, supramolecular assemblies, biopolymers, specialty polymers, and agrochemicals are all made with it.
North America is the dominant regional market, accounting for the highest revenue share in the global Ruthenium Catalyst Market and is expected to maintain its dominance throughout the forecast period. This is due to the region's growing adoption in the chemicals and electronics industries. Asia Pacific is expected to grow significantly due to rising demand in the electronics and semiconductor industries. Growing demand for ruthenium in the European healthcare industry will also contribute to market growth. Over the forecast period, the market in Latin America and the Middle East and Africa is expected to grow moderately.
Read more @ https://cmiaspireblog.blogspot.com/2022/03/ruthenium-catalyst-market-share-growth.html
